The Efficacy and Safety of Revefenacin for the Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review

• Main Authors: Jiaxing Zhang (Author), Yihong Xie (Author), Joey Sum-wing Kwong (Author), Long Ge (Author), Rui He (Author), Wenyi Zheng (Author), Jing Han (Author), Rui Zhang (Author), Huaye Zhao (Author), Yuru He (Author), Xiaosi Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Revefenacin (REV) is a novel once-daily long-acting muscarinic antagonist (LAMA) in the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD). This systematic review incorporating a dose-response meta-analysis aimed to assess the efficacy and safety of REV.Meth...